Quest Diagnostics (DGX) FY2012 results: revenue $7.4 billion, down 0.1% on the year
Quest Diagnostics Inc. (DGX) reported revenue of $7.4 billion for fiscal 2012, the year ended 31 December 2012, down 0.1% on the year before. Net income was $556 million, up 18.1%, and diluted earnings per share $3.46. The figures are the company's own, from the 10-K it filed with the SEC on 27 February 2013.
Revenue
$7.4 billion
-0.1% on the year
FY2007FY2012
Operating margin
16.3%
13.4% a year earlier
FY2007FY2012
Net income
$556 million
+18.1% on the year
FY2007FY2012
Diluted EPS
$3.46
+18.5% on the year
FY2007FY2012
this yearthe year beforeHover a bar for its figure.
The year in brief
Income statement (profit and loss)
$ million
FY2012
FY2011
FY2010
On the year
Last 8 years
Revenue
7,383
7,392
7,260
-0.1%
Cost of revenue
4,365
4,363
4,276
+0.0%
Gross profit
3,018
3,029
2,985
-0.4%
Gross margin
40.9%
41.0%
41.1%
Selling, general and administrative
1,745
1,743
1,659
+0.1%
Operating income
1,201
987
1,284
+21.7%
Operating margin
16.3%
13.4%
17.7%
Interest expense
n/a
173
148
Pre-tax income
n/a
856
1,184
Income tax
402
355
430
+13.2%
Effective tax rate
n/a
41.5%
36.3%
Net income
556
471
721
+18.1%
Net margin
7.5%
6.4%
9.9%
Diluted EPS
$3.46
$2.92
$4.05
+18.5%
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2012
FY2011
FY2010
On the year
Last 8 years
Operating cash flow
1,187
895
1,118
+32.6%
Capital expenditure
182
161
205
+13.2%
Free cash flow
1,005
734
913
+36.8%
Free cash flow margin
13.6%
9.9%
12.6%
Cash from investing
-217
-1,243
-217
Cash from financing
-822
64.0
-986
Depreciation and amortisation
287
281
254
+2.0%
Share-based compensation
50.0
71.9
53.9
-30.5%
Buybacks
200
935
750
-78.6%
Dividends paid
108
65.0
71.3
+66.4%
Dividend per share
$0.81
$0.47
$0.40
+72.3%
Diluted shares, weighted
160m
160m
177m
-0.1%
Balance sheet
$ million
FY2012
FY2011
FY2010
On the year
Last 8 years
Shareholders' equity
4,163
3,693
4,033
+12.7%
Non-controlling interest
23.0
22.1
20.6
+3.9%
Redeemable equity
0.0
n/a
n/a
Debt
3,364
4,025
2,990
-16.4%
Other liabilities
1,734
1,573
1,483
+10.2%
Total liabilities and equity
9,284
9,313
8,528
-0.3%
Fixed assets
756
800
834
-5.5%
Goodwill
5,536
5,796
5,102
-4.5%
Intangible assets
872
1,036
796
-15.8%
Trading assets
52.3
n/a
n/a
Cash and equivalents
296
165
449
+79.3%
Receivables
867
906
845
-4.4%
Inventory
93.0
89.1
76.6
+4.4%
Other assets
812
522
424
+55.6%
Total assets
9,284
9,313
8,528
-0.3%
10-K for the year ended 31 December 2012, filed 27 February 2013: the filing.